FDA Adverse Event Injury Summary report: N

MAYFIELD MODIFIED SKULL CLAMP

MDR report key: 10279360 · Received July 15, 2020

Report

Report Number
3004608878-2020-00164
Event Type
Injury
Date Received
July 15, 2020
Date of Event
March 11, 2020
Report Date
March 12, 2020
Manufacturer
INTEGRA LIFESCIENCES CORPORATION OH/USA
Product Code
HBL
PMA / PMN Number
PRE-AMEND
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION - D10, G4, G7, H2, H3, H4, H6, H10. UDI # (B)(4). THE DEVICE WAS RETURNED FOR EVALUATION. THE DHR REVIEW SHOWED NO ABNORMALITIES RELATED TO THE REPORTED FAILURE. COMPLAINT WAS UNCONFIRMED, AS THE UNIT PASSED ALL SPECIFIC FUNCTIONAL TESTS.NO FURTHER INVESTIGATION REQUIRED BASED ON THE ACCEPTABILITY OF RISK AND NO ADVERSE TRENDS IDENTIFIED. THIS WILL BE MONITORED AND TRENDED GOING FORWARD. BETWEEN 05NOV2019 AND 30JUN2020, APPROXIMATELY 2,200 MDRS SUBMITTED ELECTRONICALLY BY INTEGRA LIFESCIENCES VIA TRACKWISE, INTEGRA'S COMPLAINT HANDLING SYSTEM, WERE NOT RECEIVED BY CDRH DUE TO A COMPUTER SYSTEM ISSUE. WITHIN THIS TIME PERIOD, AN ERROR WITH INTEGRA'S MIDDLEWARE, WHICH FACILITATES COMMUNICATIONS BETWEEN TRACKWISE AND THE FDA SYSTEM, CAUSED THE COMPLAINT RECORDS TO CLOSE AND INDICATE WE HAD RECEIVED AN ACKNOWLEDGEMENT 3 FROM THE FDA WHEN WE HAD NOT. INTEGRA INTERPRETED THE ACKNOWLEDGEMENT AS A SUCCESSFUL SUBMISSION; HOWEVER, SUBSEQUENT INVESTIGATION REVEALED THE ACKNOWLEDGEMENT 3 RECEIVED WAS FROM OUR MIDDLEWARE AND NOT FROM THE FDA (THESE ACKNOWLEDGEMENTS HAVE BEEN RETAINED AS PART OF THE DOCUMENTATION OF THE MDR). THE MALFUNCTION WAS RELATED TO THE RELOCATION OF THE TRACKWISE APPLICATION TO A NEW DATA CENTER DURING THE TRANSITION OF INTEGRA'S CORPORATE HEADQUARTERS FROM PLAINSBORO, NJ TO PRINCETON, NJ. PREVIOUSLY, INTEGRA HAD BEEN SUCCESSFULLY RECEIVING ACKNOWLEDGEMENTS 1, 2, AND 3 FROM THE FDA, AND OUR RECORDS REFLECT THESE ACKNOWLEDGEMENTS, INCLUDING THE DATE AND TIME STAMPS. CAPA PR 229048 AND NC 20-011 HAVE BEEN OPENED BY INTEGRA TO FURTHER INVESTIGATE THE NONCONFORMANCE AND DEVELOP A CORRECTIVE ACTION PLAN. THE MIDDLEWARE ERROR HAS BEEN CORRECTED, AND INTEGRA HAS FILED MDRS SINCE THE CORRECTION AND VERIFIED THAT THE APPROPRIATE ACKNOWLEDGEMENTS HAVE BEEN RECEIVED FROM THE FDA. INTEGRA IS RESUBMITTING ALL IMPACTED MDR REPORTS FOR THE TIME PERIOD 05NOV2019 THROUGH 30JUN2020. INTEGRA LIFESCIENCES CONTACTED (B)(4) OFFICE OF PRODUCT EVALUATION AND QUALITY ON JULY 8-9, 2020 TO REPORT THESE ISSUES REGARDING MDR REPORTS.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT YET RETURNED TO THE MANUFACTURER FOR ANALYSIS. THE PLANT INVESTIGATION IS IN PROGRESS AND A SUPPLEMENTAL MEDWATCH REPORT WILL BE SUBMITTED UPON COMPLETION OF THE INVESTIGATION. LINKED TO MFG REPORT NUMBER 3004608878-2020-00165.

Description of Event or Problem · 1

THIS IS 1 OF 2 REPORTS. IT WAS REPORTED THAT A PATIENT HAD UNDERGONE A POSTERIOR CERVICAL FORAMINOTOMIES ON (B)(6) 2020. THE PATIENT'S HEAD SLIPPED OUT OF THE A1059 MAYFIELD MODIFIED SKULL CLAMP AS SOON AS THE PATIENT WAS FLIPPED AND ATTACHED TO A CERVICAL MANAGEMENT ATTACHMENT. THE PATIENT SUSTAINED A LACERATION WHICH WAS CLOSED WITH SUTURES. AN UNSPECIFIED SURGICAL TIME WAS REPORTED DUE TO THE PATIENT WAS PLACED IN SUPINE POSITION AND THEN WAS REPINED. REQUEST FOR ADDITIONAL INFORMATION HAS BEEN SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
741432 MAYFIELD MODIFIED SKULL CLAMP N/A HBL INTEGRA LIFESCIENCES CORPORATION OH/USA

Patients

Seq Age Sex Outcome Treatment
1